Washington [US], October 20 (ANI): Two new studies indicate that immunotherapy may benefit people with leptomeningeal carcinomatosis (LMD), a rare but serious complication of cancer that has spread to the brain and/or spinal cord. The research was led by investigators at Massachusetts Genera
Washington [US], October 16 (ANI): A recent study provides insights into why some types of colorectal cancer don't respond to immune checkpoint inhibitors and offers a strategy to overcome their resistance.
Washington [US], October 12 (ANI): Immune checkpoint inhibitors, which unleash the immune response against tumor cells, have revolutionized cancer treatment; however, the medications aren't effective in a large number of patients, including those with colorectal cancer.
Pennsylvania [US], September 20 (ANI): According to the results of an international, randomized phase III clinical trial led by UPMC Hillman Cancer Center, immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma.
Washington [US], September 3 (ANI): In a new study by Yale Cancer Center, researchers show stem-like T cells within certain lymph nodes could be natural cancer fighters. Targeting these T cells, which are a type of white blood cells, with immunotherapy drugs could increase the number of canc
Washington [US], August 1 (ANI): According to a new study led by Vanderbilt University Medical Center, a biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients.
Maryland [US], July 30 (ANI): During a recent study, researchers found that a combination of the immunotherapy drug nivolumab and the kinase-inhibitor drug cabozantinib can make curative surgery possible in some liver cancer patients who would normally not be considered surgical candidates.
Washington [US], July 27 (ANI): A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients, according to a new study led by Vanderbilt University Medical Center.
Washington [US], June 28 (ANI): During a new study, researchers at McMaster University developed promising new cancer immunotherapy by using cancer-killing cells, genetically engineered outside the body to find and destroy malignant tumors.
Washington [US], June 15 (ANI): Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, suggested a new study led by cancer researchers at UT Southwestern Medical Center.
Washington [US], June 4 (ANI): Researchers at the Memorial Sloan Kettering Cancer Center (MSK) found that patients who received nivolumab after bladder cancer surgery reduced their overall risk for high-grade bladder cancer recurrence. This research was published in the journal New England J
Washington [US], May 2 (ANI): A multi-institutional study, drove by the Proceedings of the National Academy of Sciences journal, distinguished both the hereditary abnormalities that drive pre-cancer cells that lead to an intrusive kind of head and neck cancer and patients who are liable to r